Canada · Delayed Price · Currency is CAD Inozyme Pharma Statistics
Total Valuation
TSXV:TBRD has a market cap or net worth of CAD 78.18 million. The enterprise value is 63.53 million.
| Market Cap | 78.18M |
| Enterprise Value | 63.53M |
Important Dates
The next estimated earnings date is Thursday, October 9, 2025.
| Earnings Date | Oct 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:TBRD has 49.17 million shares outstanding. The number of shares has increased by 8.49% in one year.
| Current Share Class | 49.17M |
| Shares Outstanding | 49.17M |
| Shares Change (YoY) | +8.49% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 1.76% |
| Owned by Institutions (%) | 21.75% |
| Float | 39.96M |
Valuation Ratios
The trailing PE ratio is 12.24 and the forward PE ratio is 10.43.
| PE Ratio | 12.24 |
| Forward PE | 10.43 |
| PS Ratio | 0.41 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | 2.78 |
| P/OCF Ratio | 2.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.73, with an EV/FCF ratio of 2.26.
| EV / Earnings | 9.05 |
| EV / Sales | 0.33 |
| EV / EBITDA | 1.73 |
| EV / EBIT | 6.03 |
| EV / FCF | 2.26 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.32 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 0.67 |
| Debt / FCF | 0.87 |
| Interest Coverage | 6.92 |
Financial Efficiency
Return on equity (ROE) is 9.89% and return on invested capital (ROIC) is 6.12%.
| Return on Equity (ROE) | 9.89% |
| Return on Assets (ROA) | 3.61% |
| Return on Invested Capital (ROIC) | 6.12% |
| Return on Capital Employed (ROCE) | 11.23% |
| Revenue Per Employee | 2.84M |
| Profits Per Employee | 104,821 |
| Employee Count | 67 |
| Asset Turnover | 1.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TSXV:TBRD has paid 2.76 million in taxes.
| Income Tax | 2.76M |
| Effective Tax Rate | 28.24% |
Stock Price Statistics
The stock price has decreased by -22.44% in the last 52 weeks. The beta is 1.11, so TSXV:TBRD's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -22.44% |
| 50-Day Moving Average | 1.62 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 35.29 |
| Average Volume (20 Days) | 73,692 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:TBRD had revenue of CAD 190.12 million and earned 7.02 million in profits. Earnings per share was 0.13.
| Revenue | 190.12M |
| Gross Profit | 41.53M |
| Operating Income | 10.54M |
| Pretax Income | 9.79M |
| Net Income | 7.02M |
| EBITDA | 30.49M |
| EBIT | 10.54M |
| Earnings Per Share (EPS) | 0.13 |
Balance Sheet
The company has 39.68 million in cash and 24.62 million in debt, giving a net cash position of 15.07 million or 0.31 per share.
| Cash & Cash Equivalents | 39.68M |
| Total Debt | 24.62M |
| Net Cash | 15.07M |
| Net Cash Per Share | 0.31 |
| Equity (Book Value) | 75.01M |
| Book Value Per Share | 1.49 |
| Working Capital | 25.50M |
Cash Flow
In the last 12 months, operating cash flow was 29.55 million and capital expenditures -1.41 million, giving a free cash flow of 28.14 million.
| Operating Cash Flow | 29.55M |
| Capital Expenditures | -1.41M |
| Free Cash Flow | 28.14M |
| FCF Per Share | 0.57 |
Margins
Gross margin is 21.84%, with operating and profit margins of 5.54% and 3.69%.
| Gross Margin | 21.84% |
| Operating Margin | 5.54% |
| Pretax Margin | 5.15% |
| Profit Margin | 3.69% |
| EBITDA Margin | 16.04% |
| EBIT Margin | 5.54% |
| FCF Margin | 14.80% |
Dividends & Yields
TSXV:TBRD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.49% |
| Shareholder Yield | n/a |
| Earnings Yield | 8.98% |
| FCF Yield | 35.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSXV:TBRD has an Altman Z-Score of 2.02 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.02 |
| Piotroski F-Score | 6 |